24 November 2020
Between July and November 2020, we reached out to people living with and who have experienced drug-resistant infections to better understand how the Covid-19 pandemic is shaping their lives. We spoke to medical professionals, doctors and pharmacists, to capture their perspectives too. Combined, the stories shared today in our new report — AMR Voices — provides a first-hand look at how the antimicrobial resistance (AMR) and Covid-19 agendas meet. With stories from the UK, US, South Africa and India, we have captured what people living with resistant infections — and those who have overcome them — think needs to change when it comes to acting on this “slow-moving” pandemic.